MoonLake Immunotherapeutics
MLTX
#3443
Rank
C$4.56 B
Marketcap
$72.40
Share price
4.09%
Change (1 day)
23.64%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -C$0.11 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$75.57 Million, an increase over its 2022 earnings that were of -C$90.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.11 Billion40.65%
2023 -C$75.57 Million-16.81%
2022 -C$90.84 Million